Please login to the form below

IGAS

This page shows the latest IGAS news and features for those working in and with pharma, biotech and healthcare.

Novartis receives FDA breakthrough therapy designation for rare disease med

This includes IgA nephropathy (IgAN), atypical hemolytic uremic syndrome (aHUS), and membranous nephropathy (MN). ... The European Medicines Agency (EMA) has also granted iptacopan a PRIME designation in C3G, as well as an orphan drug designation for the

Latest news

Incyte’s JAK inhibitor cream clears second eczema trial

In both trials, significantly more patients treated with ruxolitinib cream (0.75% or 1.5%) achieved Investigator’s Global Assessment Treatment Success (IGA-TS) than patients treated with a control ... Success was defined as an IGA score of 0 (clear skin
Sanofi indicted in France over epilepsy drug birth defects

The following year, France’s social affairs inspection agency IGAS took issue with what it said was a slow response by the health authorities and Sanofi to updating the labelling of ... IGAS has estimated that between 2006 and 2014, somewhere between
UCB’s bimekizumab beats AbbVie’s Humira in phase 3 trial

investigator global assessment (IGA) response of clear or almost clear.
J&J's Tremfya filed for approval in US for psoriatic arthritis

CRP), improvement in physical function (HAQ-DI), skin clearance (IGA) and quality of life (SF-36 PCS and MCS).
Tremfya heads for filing in psoriatic arthritis

DAS-28 CRP), improvement in physical function (HAQ-DI), skin clearance (IGA), and quality of life (SF-36 PCS and MCS).

More from news
Approximately 1 fully matching, plus 15 partially matching documents found.

Latest appointments

New hires at Nanoform, Leo Pharma and Calliditas

IgA nephropathy (IgAN) – also known as Berger’s disease. ... Currently, there are no approved treatments for IgA Nephropathy, and Nefecon has the potential to be a disease-modifying treatment for patients suffering from this chronic autoimmune disease

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Hayward Medical Communications launch a new, eye-opening journal

Hayward is particularly pleased that the journal features regular columns from the International Glaucoma Association (IGA) and the Royal National Institute of Blind People (RNIB). .

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Commercial Finance Director, Healthcare Marketing Communications...: up to £90K

Account Director – Creative Healthcare Communications: Competative

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Healthcare Lead Copywriter: Competitive

Healthcare Account Director: Competitive

Medical Editor: Competitive

Healthcare Senior Account Manager: Competitive

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

PMHub

Add my company

Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Mistrust in medical research: a patient perspective: The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease: Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients: We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...